Work

Reply: Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 COURAGE Trial

Year: 2024

Type: letter

Abstract: Reply: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial

Source: The Journal of Urology

DOI: 10.1097/ju.0000000000004291

Authors: David Staskin, Janet Owens-Grillo, Elizabeth Thomas, Eric Rovner

Institutions: Tufts University, Sumitomo Dainippon Pharma (United States), Medical University of South Carolina

Language: English

Topic: Urinary Bladder and Prostate Research

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,000

OpenAlex ID: W4403688659

Cites:

Cited by:

Related to: 10